Released Title Price Sensitive Download Types
2021-01-04 09:16:10 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/67502599bc6956848aeaa75d6f59bf92
    Director's Interest
2021-01-04 16:32:57 Resignation and Appointment of Joint Company Secretary 0 https://app.sharelinktechnologies.com/announcement/asx/d7695187c680a184e77fdb4b6b63e0c0
    Appointment / Resignation
2021-01-07 09:33:43 Recruitment of head & neck cancer patients completed for ph2 1 https://app.sharelinktechnologies.com/announcement/asx/82f1bcf481af4c19ab2823bf7cb417e7
    Progress Report
2021-01-22 08:54:06 Ulcerative Colitis Phase II Study of GSK2831781 Discontinued 1 https://app.sharelinktechnologies.com/announcement/asx/24a24cc10afd92b404b3f53066a8a1f6
    Progress Report
2021-01-22 08:57:56 Immutep Quarterly Activities Report & Appendix 4C 1 https://app.sharelinktechnologies.com/announcement/asx/3b8b635cd447b8b48ad3b52e2a77a831
    Quarterly Reports
2021-01-27 08:59:30 Phase II study for eftilagimod alpha in COVID-19 advances 1 https://app.sharelinktechnologies.com/announcement/asx/1289dd96da2bd9a7ca9fe9d9ed6585b6
    Progress Report
2021-02-02 08:22:30 Immutep Corporate Presentation 0 https://app.sharelinktechnologies.com/announcement/asx/aea716480ae18175eb5807bbd4b92211
    Periodic Report General
2021-02-23 16:23:40 Half Yearly Report and Accounts 1 https://app.sharelinktechnologies.com/announcement/asx/f1574d99b63bc50c833202232bed9de1
    Periodic Report General
    Half Year Reports
2021-03-05 08:21:33 Immutep expands Part B of TACTI-002 collaboration trial 1 https://app.sharelinktechnologies.com/announcement/asx/3ac47f555a8fa3142c5ef8d276a72fa0
    Progress Report
2021-03-09 16:14:44 Immutep secures second US patent grant for eftilagimod alpha 1 https://app.sharelinktechnologies.com/announcement/asx/22f72eec77321ac86c5ab227b7742952
    Progress Report
2021-03-12 17:02:42 S&P DJI Announces March 2021 Quarterly Rebalance 1 https://app.sharelinktechnologies.com/announcement/asx/b3c00a05b6348d3937182d6d6fa896ae
    Company Report General
2021-03-16 08:17:13 Immutep collaborates with MSD for phase 2b head & neck trial 1 https://app.sharelinktechnologies.com/announcement/asx/b86a516c80a80b32c17094f5d9a04b05
    Progress Report
2021-03-18 10:59:19 Appendix 2A 0 https://app.sharelinktechnologies.com/announcement/asx/973461423165cf52e63462b8688fdf60
    Issued Capital General
2021-04-01 08:22:40 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/52d6d69e287410dd4b27617dabd844d0
    Substantial Holdings
2021-04-07 08:28:26 Immutep announces European Patent Grant for LAG525 1 https://app.sharelinktechnologies.com/announcement/asx/745fd306f2e3be3880e85c70fe22d382
    Progress Report
2021-04-08 07:52:38 Immutep achieves Fast Track designation for Efti from US FDA 1 https://app.sharelinktechnologies.com/announcement/asx/7899ad293ca759b4fb6612c92eab84e6
    Progress Report
2021-04-14 09:25:43 Immutep Investor Update 0 https://app.sharelinktechnologies.com/announcement/asx/d3cb4ed1244da127075f921d0763cebf
    Periodic Report General
2021-04-16 17:46:01 Immutep receives A$1,155,055 R&D Tax Incentive 1 https://app.sharelinktechnologies.com/announcement/asx/dfb5306daa0124a225ab336c3f21678e
    Periodic Report General
2021-04-19 09:40:25 Immutep Quarterly Activities Report & Appendix 4C 1 https://app.sharelinktechnologies.com/announcement/asx/4a1b39fa5f7ce36035b5bf37be762914
    Quarterly Reports
2021-04-29 07:31:10 TACTI-002 & INSIGHT-004 data to be presented at ASCO 1 https://app.sharelinktechnologies.com/announcement/asx/8a80b788f5d5adf327ec81995b88ed77
    Progress Report
2021-05-07 09:49:30 Operational Update 1 https://app.sharelinktechnologies.com/announcement/asx/59b5bb33016a92fcc8a4c8bab8efa4a1
    Progress Report
2021-05-13 11:51:41 Immutep Corporate Presentation 0 https://app.sharelinktechnologies.com/announcement/asx/31ec678ef67ad711896823e8635bd8b0
    Periodic Report General
2021-05-14 10:55:43 Appendix 2A 0 https://app.sharelinktechnologies.com/announcement/asx/f6adceabb3b987c9f82eec0516814165
    Issued Capital General
2021-05-18 08:20:58 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/1b4dfb2beb779675f6bd8974217b3e90
    Substantial Holdings
2021-05-20 08:22:49 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/642ef07acf67a7a18b5e35d5258d042e
    Substantial Holdings
2021-05-20 13:07:16 TACTI-002 and INSIGHT-004 abstracts for ASCO 2021 0 https://app.sharelinktechnologies.com/announcement/asx/a771b675b8e9d09e791110b1c0ed1755
    Progress Report
2021-05-25 08:16:44 Immutep to present at Jefferies Healthcare Conference 0 https://app.sharelinktechnologies.com/announcement/asx/209ec15b58ae6e926e41b15a95af9dbc
    Company Report General
2021-05-26 13:32:34 Immutep granted Chinese patent for its LAG-3 candidate Efti 1 https://app.sharelinktechnologies.com/announcement/asx/8ecfb5b8c763d6c99c8c54f409119d1d
    Progress Report
2021-06-01 08:20:32 Immutep enters New Collaboration with Merck KGaA for Efti 1 https://app.sharelinktechnologies.com/announcement/asx/42a6739542be0a78d77e062e0bd60a78
    Progress Report
2021-06-02 11:13:26 Immutep granted European patent for its LAG-3 candidate Efti 1 https://app.sharelinktechnologies.com/announcement/asx/591e3d520d48fe83db098124c7c51963
    Progress Report
2021-06-04 16:14:25 Immutep Reports Positive Final Data from INSIGHT-004 trial 1 https://app.sharelinktechnologies.com/announcement/asx/1808fb0baf96f13c0071e20a8ffeda8d
    Progress Report
2021-06-04 16:17:05 Immutep Reports Positive Data from its TACTI-002 ph 2 trial 1 https://app.sharelinktechnologies.com/announcement/asx/95f5ad4796df4572b5a55330527bbdff
    Company Report General
    Progress Report
2021-06-04 16:19:15 Immutep presentation for Jefferies Healthcare Conference 0 https://app.sharelinktechnologies.com/announcement/asx/305ac65fd98b8f6a28d6c2a0e208f117
    Periodic Report General
2021-06-07 16:01:55 Application for quotation of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/90bddbf3a13d74942152cfe62d8651a1
    Issued Capital General
2021-06-08 07:37:30 Immutep Reveals a New anti-LAG-3 Research Program 1 https://app.sharelinktechnologies.com/announcement/asx/6fb0292713151cc624307f80d9f99934
    Progress Report
2021-06-08 16:11:07 Appendix 2A 0 https://app.sharelinktechnologies.com/announcement/asx/e2344485ba4e1786179e28b6550a2e48
    Issued Capital General
2021-06-09 19:21:15 Immutep global webcast slides 1 https://app.sharelinktechnologies.com/announcement/asx/7cddf9bc3829bae5c2c95d9cab747437
    Company Report General
    Periodic Report General
2021-06-15 08:17:38 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/77d4a862ffb183614121507f0f8fd7c3
    Substantial Holdings
2021-06-17 08:20:17 Trading Halt 1 https://app.sharelinktechnologies.com/announcement/asx/6ad543e25bb3d85783852a4124c621fa
    Trading Halt
2021-06-21 09:47:15 Immutep secures commitments for A$60 million in a Placement 1 https://app.sharelinktechnologies.com/announcement/asx/ab958e644dfafa46d170a61d74e973f0
    Company Administration General
    Issued Capital General
    Placement
    Stock Exchange Announcement Ge
2021-06-21 09:47:30 Immutep Capital Raising Presentation 1 https://app.sharelinktechnologies.com/announcement/asx/33e59c1d71fc0c2ab0dea86dbb9cadcd
    Periodic Report General
2021-06-21 09:48:00 Proposed issue of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/a0edf21fe6546ff42d357fe4b0e3f1cd
    Issued Capital General
2021-06-21 09:48:10 Efti to be evaluated in new triple combination therapy trial 1 https://app.sharelinktechnologies.com/announcement/asx/082a74064153756efe2b8bfde513824f
    Progress Report
2021-06-25 11:39:15 Application for quotation of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/849396b8e9d75d357abd6c9722aef062
    Issued Capital General
2021-06-25 16:04:36 Share Purchase Plan Offer Documents 0 https://app.sharelinktechnologies.com/announcement/asx/763d9675703a48d1cf152a268839577c
    Issued Capital General
    Letter to Shareholders
2021-06-25 16:15:27 Notice of Extraordinary General Meeting/Proxy Form 0 https://app.sharelinktechnologies.com/announcement/asx/31f80bd4c74b3bf69db41725b4e1fe61
    Notice of Meeting
2021-06-28 08:11:40 Cleansing Notice 0 https://app.sharelinktechnologies.com/announcement/asx/dfa23710009d7fc38fada84ac8ec15a2
    Issued Capital General
2021-06-30 08:19:30 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/47b933e732d84eb925e7dfaad8d92eea
    Substantial Holdings
2021-06-30 12:28:36 Change in substantial holding for IMM 0 https://app.sharelinktechnologies.com/announcement/asx/b705d99d3bd173258fab842f7c21dcc9
    Substantial Holdings
2021-07-05 16:34:30 Proposed issue of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/a1016530e0f00f6403c60dc4d6e6d464
    Issued Capital General
2021-07-06 08:58:10 US FDA & IRB approves start of ph2b head & neck cancer trial 1 https://app.sharelinktechnologies.com/announcement/asx/3192276da7d24d7468a9fa2974399a5e
    Progress Report
2021-07-13 09:48:49 Immutep Quarterly Activities Report & Appendix 4C 1 https://app.sharelinktechnologies.com/announcement/asx/122735e6d48812155a816b390a786804
    Quarterly Reports
2021-07-15 13:10:30 EGM - Now to be Held as an Online Virtual Meeting 0 https://app.sharelinktechnologies.com/announcement/asx/bc4ff398c8c12853956de4fb98e759d1
    Company Report General
    Notice of Meeting
2021-07-21 09:00:32 Completion of Share Purchase Plan 1 https://app.sharelinktechnologies.com/announcement/asx/37b9e7d8b3a0bdd3008ec44603fe61e9
    Issued Capital General
2021-07-23 08:25:07 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/5a7015e2e18ca15f52910b458d445858
    Substantial Holdings
2021-07-23 08:25:27 Application for quotation of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/3e1fa0c382d89ffa34c084a9428538e6
    Issued Capital General
2021-07-26 11:56:09 2021 EGM Presentation 0 https://app.sharelinktechnologies.com/announcement/asx/95caf20b307ad8ff25bfeb953faf215c
    Periodic Report General
2021-07-26 12:04:59 Chairmans EGM Address 0 https://app.sharelinktechnologies.com/announcement/asx/9b0d4fd5dccdc43a1eb6f53b375465bb
    Chairman's Address
2021-07-26 18:37:56 Results of EGM 0 https://app.sharelinktechnologies.com/announcement/asx/6e579a400f83febe287bae43b3620dca
    Notice of Meeting
2021-07-27 08:15:20 Proposed issue of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/2f6ef470553dce5eb5ea4c35475e99c9
    Issued Capital General
2021-07-27 08:19:25 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/bc83ee57d8f01adf6befa69664d25d36
    Substantial Holdings
2021-07-29 08:22:05 Application for quotation of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/cdc8d3ca7ba89dbcb457d983f6824e97
    Issued Capital General
2021-07-30 09:24:23 Completion of Placement - Tranche 2 1 https://app.sharelinktechnologies.com/announcement/asx/e22870081341f52f4916d789d7de44e7
    Placement
2021-07-30 10:03:53 Cleansing Notice 0 https://app.sharelinktechnologies.com/announcement/asx/522a66a008279f39eb26ff8f247d3549
    Issued Capital General
2021-08-03 08:21:21 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/ee6531e35362e65cdaab50f551a71f89
    Substantial Holdings
2021-08-03 19:18:45 Becoming a substantial holder 0 https://app.sharelinktechnologies.com/announcement/asx/7e2d7fe090908d83f129dfda5328a73c
    Substantial Holdings
2021-08-05 08:18:41 INSIGHT-003 investigator-initiated trial - 1st patient dosed 1 https://app.sharelinktechnologies.com/announcement/asx/3f0d47509fb509be38594161551342aa
    Progress Report
2021-08-27 08:04:08 Chinese patent granted for anti-LAG-3 antibody LAG525 1 https://app.sharelinktechnologies.com/announcement/asx/a6c41274cbfe69455f62ef2789e2af0e
    Progress Report
2021-08-30 19:08:14 Appendix 4E & 2021 Full Year Statutory Accounts 1 https://app.sharelinktechnologies.com/announcement/asx/6db61fa9d3fe1f3de494f424e0c6c333
    Periodic Report General
    Annual report
    Full Year Reports
    Preliminary Final Report
    Top 20 Shareholders
2021-08-31 08:46:09 Immuteps partner, EOC Pharma, expands efti trial pipeline 1 https://app.sharelinktechnologies.com/announcement/asx/131df0ccfadbf9d5ee649541b27bd869
    Progress Report
2021-09-01 10:07:07 Recruitment of patients completed for Part B of TACTI-002 1 https://app.sharelinktechnologies.com/announcement/asx/c55228d76ba0a5b4c2d1aa651aef5a8f
    Progress Report
2021-09-21 18:38:10 Immutep to present final AIPAC Overall Survival data at SITC 0 https://app.sharelinktechnologies.com/announcement/asx/7dc0b5ea7b15bf055ca5db6ae676f68c
    Company Administration General
    Progress Report
2021-09-27 18:37:43 Immutep Corporate Presentation 0 https://app.sharelinktechnologies.com/announcement/asx/fdba1b86cc9fbb2bc763c886ad18c4ff
    Periodic Report General
2021-09-28 12:09:54 Immutep to Present at Healthcare Investor Conferences 0 https://app.sharelinktechnologies.com/announcement/asx/b9adc2872e95a803e9adc39d19c93a5b
    Company Report General
2021-09-29 08:47:41 Immutep Receives A$3.4 million R&D French Tax Incentive 1 https://app.sharelinktechnologies.com/announcement/asx/18968fd94d0223e278da9b3e1e286e4d
    Company Administration General
    Progress Report
2021-10-01 11:55:14 Application for quotation of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/a2932469f4270233dd152ecd7e84e5bc
    Issued Capital General
2021-10-01 16:16:20 Notification regarding unquoted securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/8af76d2d0ad8bf88eba960b9bbbf47cd
    Issued Capital General
2021-10-04 08:24:40 Immutep to present Phase II TACTI-002 data at SITC 2021 0 https://app.sharelinktechnologies.com/announcement/asx/e7aba18eefa297e1618b88cf6899375a
    Progress Report
2021-10-04 09:25:16 Change of Directors Interest Notice - Mr Meyers 0 https://app.sharelinktechnologies.com/announcement/asx/65a6cf4296b6ade4b8b7a40ca4458d18
    Director's Interest
2021-10-04 09:27:41 Change of Directors Interest Notice - Mr Chamberlain 0 https://app.sharelinktechnologies.com/announcement/asx/555833913c4641d3264db5b6c61fecb4
    Director's Interest
2021-10-07 08:46:10 Ceasing to be a substantial holder for IMM 0 https://app.sharelinktechnologies.com/announcement/asx/10711e27b3c30ee496cbdc906f5b7e8b
    Substantial Holdings
2021-10-12 19:03:53 2021 AGM & Key Dates 0 https://app.sharelinktechnologies.com/announcement/asx/9f49677665366e8d0b1a6682b02d39b4
    Notice of Meeting
2021-10-26 09:05:18 Annual Report filed on Form 20-F with SEC 0 https://app.sharelinktechnologies.com/announcement/asx/b0f62e80e6ecc14180d2b30adfc03fc9
    Annual report
2021-10-26 09:14:58 Annual Report to shareholders 0 https://app.sharelinktechnologies.com/announcement/asx/c0809b95853c4105c6c400605f633806
    Periodic Report General
    Annual report
    Full Year Reports
    Top 20 Shareholders
2021-10-26 09:39:18 Appendix 4G 0 https://app.sharelinktechnologies.com/announcement/asx/0058365395af7fcd6b500bf2f667c8b1
    Periodic Report General
2021-10-26 10:35:13 Notice of Annual General Meeting/Proxy Form 0 https://app.sharelinktechnologies.com/announcement/asx/5fc9ac69fb48c4ecf3f4e8f754ebf55d
    Notice of Meeting
2021-10-28 08:30:15 Immutep Quarterly Activities Report & Appendix 4C 1 https://app.sharelinktechnologies.com/announcement/asx/161a04879a780e539497739ba80e9445
    Quarterly Reports
2021-10-29 08:19:54 Immutep receives EMA scientific advice for Phase 3 in MBC 1 https://app.sharelinktechnologies.com/announcement/asx/7aab715318e9a6c78f2d6b259717a800
    Company Administration General
    Progress Report
2021-11-02 10:57:36 Immutep granted Chinese Patent for eftilagimod alpha 1 https://app.sharelinktechnologies.com/announcement/asx/aa47dd5339f0675b08e30d4d10eec96a
    Progress Report
2021-11-08 16:18:24 JobKeeper Payment Notice 0 https://app.sharelinktechnologies.com/announcement/asx/a5cb9549eb1098e25577c5a893fde770
    Periodic Report General
2021-11-10 08:24:03 Final Phase IIb AIPAC clinical trial results for Efti in MBC 1 https://app.sharelinktechnologies.com/announcement/asx/1dd27a9adb8fe7d531b2f8d10250b06d
    Progress Report
2021-11-10 08:24:58 Immutep announces publication of SITC 2021 abstracts 1 https://app.sharelinktechnologies.com/announcement/asx/3bbc4b04df81715042b317bf8b2ac10d
    Company Administration General
    Progress Report
2021-11-15 08:37:17 Chinese Patent Granted for Efti with PD-1 Pathway Inhibitors 1 https://app.sharelinktechnologies.com/announcement/asx/7513c29a4ff7c5f37a61abc523393b84
    Progress Report
2021-11-15 08:37:44 Immutep announces publication of SITC 2021 posters 1 https://app.sharelinktechnologies.com/announcement/asx/38b2d53d1d5bbe285a23c210b8ea3120
    Company Report General
    Progress Report
2021-11-16 18:19:01 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/aaa59b5cbcd5f6879b9a273681b3e644
    Substantial Holdings
2021-11-17 07:30:55 Immutep Global Webcast Slides to Discuss Clinical Results 1 https://app.sharelinktechnologies.com/announcement/asx/726356e56f93d2b2a8d253b545ace44b
    Periodic Report General
2021-11-17 08:17:55 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/8f7bd5f10bad201a4510c1f102762f1f
    Substantial Holdings
2021-11-19 08:30:54 Phase II TACTI-002 trial recruitment successfully completed 1 https://app.sharelinktechnologies.com/announcement/asx/96a710dc7bd033dc91ae843e55bb82e5
    Progress Report
2021-11-26 08:16:53 Immutep AGM 2021 - Chairmans Address 0 https://app.sharelinktechnologies.com/announcement/asx/ac259ccf813434e8e45c77e341d0dc96
    Chairman's Address
2021-11-26 08:17:03 Immutep AGM 2021 - CEOs Presentation 0 https://app.sharelinktechnologies.com/announcement/asx/38f03deab850cf01259740f3aac6e300
    Chairman's Address
    Periodic Report General
2021-11-26 12:35:05 Results of Meeting 0 https://app.sharelinktechnologies.com/announcement/asx/1c4fb57ad36e52775e4647aa9a890610
    Notice of Meeting
Powered by Share Link